Personalized Medicine May Necessitate Increased Focus On Drug Quality
This article was originally published in The Pink Sheet Daily
Executive Summary
FDA Office of Biotechnology Products Director says promise of personalized medicine may place greater burden on pharma to ensure drugs work as intended in target populations.